Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - TOTAL CURRENT LIABILITIES
Total Current Liabilities SGMO - Sangamo Therapeutics, Inc.
47.7 M
LAST VALUE
-38.91%
2 YEAR CAGR
-9.47%
5 YEAR CAGR
16.77%
10 YEAR CAGR